All Stories

  1. CSF levels of the endocannabinoid anandamide are reduced in patients with untreated narcolepsy type 1: a pilot study
  2. Dream Recall and Content versus the Menstrual Cycle: A Cross-Sectional Study in Healthy Women
  3. Sleep Complaints, Sleep and Breathing Disorders in Myotonic Dystrophy Type 2
  4. Alzheimer's disease and late-onset epilepsy of unknown origin: two faces of beta amyloid pathology
  5. Comparative Sleep Disturbances in Myotonic Dystrophy Types 1 and 2
  6. Insight into epileptic and physiological déjà vu : from a multicentric cohort study
  7. Profile of pitolisant in the management of narcolepsy: design, development, and place in therapy
  8. Restless legs syndrome is highly prevalent in patients with postpolio syndrome
  9. Complement system dysregulation in patients affected by Idiopathic Generalized Epilepsy and the effect of antiepileptic treatment
  10. Posterior Reversible Encephalopathy Syndrome after Hematopoietic Cell Transplantation in Children with Hemoglobinopathies
  11. Validation Study of Italian Version of Inventory for Déjà Vu Experiences Assessment (I-IDEA): A Screening Tool to Detect Déjà Vu Phenomenon in Italian Healthy Individuals
  12. Validation Study of Italian Version of Inventory for DéJà vu Experiences Assessment (I-IDEA): A Screening Tool to Detect DéJà vu Phenomenon in Italian Healthy Individuals
  13. Effects of adjunctive perampanel on sleep quality, daytime somnolence and cognition in refractory focal epilepsy: further data.
  14. Obstructive Sleep Apnea is Associated With Early but Possibly Modifiable Alzheimer’s Disease Biomarkers Changes
  15. Cardiac Autonomic Changes in Epilepsy
  16. Vitamin D status of male OSAS patients improved after long-term CPAP treatment mainly in obese subjects
  17. Epilepsy, amyloid-β, and D1 dopamine receptors: a possible pathogenetic link?
  18. Predicting seizures in untreated temporal lobe epilepsy using point-process nonlinear models of heartbeat dynamics
  19. Rapid eye movement sleep disruption and sleep fragmentation are associated with increased orexin-A cerebrospinal-fluid levels in mild cognitive impairment due to Alzheimer's disease
  20. Heart rate variability in untreated newly diagnosed temporal lobe epilepsy: Evidence for ictal sympathetic dysregulation
  21. Beta-amyloid and phosphorylated tau metabolism changes in narcolepsy over time
  22. Obstructive sleep apnoea as a risk factor for osteopenia and osteoporosis in the male population
  23. Optic Nerve Dysfunction in Obstructive Sleep Apnea: An Electrophysiological Study
  24. Estrogen Deficiency Hampers the Beneficial Effect of Continuous Positive Airway Pressure Therapy on Serum Vitamin D Concentrations in Postmenopausal Women Affected by Obstructive Sleep Apnea
  25. Effective treatment of nocturnal frontal lobe epilepsy with lacosamide: a report of two cases
  26. Erratum
  27. Chronic dopaminergic treatment in restless legs syndrome: does it affect the autonomic nervous system?
  28. MicroRNA expression is dysregulated in narcolepsy: a new evidence?
  29. Continuous Positive Airway Pressure Treatment Increases Serum Vitamin D Levels in Male Patients with Obstructive Sleep Apnea
  30. Zonisamide in the management of epilepsy in the elderly
  31. Folic Acid Supplements During Pregnancy in Specific Clinical Settings
  32. Epilepsy surgery in adult-onset Rasmussen’s encephalitis: case series and review of the literature
  33. Evidence of hydrogen sulfide involvement in amyotrophic lateral sclerosis
  34. Nocturnal frontal lobe epilepsy with paroxysmal arousals due to CHRNA2 loss of function
  35. Restless Legs Syndrome and Poliomyelitis: New Evidences of an Old Observation?
  36. Refractory restless legs syndrome remitting after dual kidney transplantation
  37. Acute postoperative seizures and long-term seizure outcome after surgery for hippocampal sclerosis
  38. Oral l-carnitine as treatment for narcolepsy without cataplexy during pregnancy: A case report
  39. Symptomatic nonconvulsive status epilepticus erroneously suggestive of sporadic Creutzfeldt–Jakob disease
  40. Amelioration of Untreated Restless Legs Syndrome by Tadalafil in a Patient With Erectile Dysfunction
  41. Bilateral thalamic stroke due to nasal ephedrine and naphazoline use
  42. Orexinergic System Dysregulation, Sleep Impairment, and Cognitive Decline in Alzheimer Disease
  43. Restless legs syndrome and post polio syndrome: a case−control study
  44. May CSF beta-amyloid and tau proteins levels be influenced by long treatment duration and stable medication in narcolepsy?
  45. Is autonomic nervous system involved in restless legs syndrome during wakefulness?
  46. Multiple sleep latency test may be not sensitive in obstructive sleep apnea with comorbid narcolepsy revealed by low cerebrospinal fluid orexin levels
  47. Cerebrospinal-fluid orexin levels and daytime somnolence in frontotemporal dementia
  48. Restless legs syndrome and daytime sleepiness are prominent in myotonic dystrophy type 2
  49. Can nocturnal groaning be suspected by cardiorespiratory polygraphy?
  50. Circadian Fatigue or Unrecognized Restless Legs Syndrome? The Post-Polio Syndrome Model
  51. Circadian variation of fatigue in paralytic poliomyelitis and postpolio syndrome: just fatigue or masked restless legs syndrome?
  52. Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children
  53. Effects of epilepsy treatment on sleep architecture and daytime sleepiness: An evidence-based review of objective sleep metrics
  54. Sleep disorders in spinal and bulbar muscular atrophy (Kennedy’s disease): a controlled polysomnographic and self-reported questionnaires study
  55. CSF beta-amyloid levels are altered in narcolepsy: a link with the inflammatory hypothesis?
  56. Fronto-central monomorphic theta activity as EEG pattern of ictal psychosis
  57. Topiramate-induced periodic limb movement disorder in a patient affected by focal epilepsy
  58. Lacosamide as add-on treatment of focal symptomatic epilepsy in a patient with alcoholic liver cirrhosis
  59. Unexpected total recovery in a patient with post-anoxic complete alpha coma predicted by recording of cortical SEPs
  60. Electrophysiological and amperometric evidence that modafinil blocks the dopamine uptake transporter to induce behavioral activation
  61. Improvement of Restless Legs Syndrome by Varenicline as Antismoking Treatment
  62. Sleep disorders in myotonic dystrophy type 2: a controlled polysomnographic study and self-reported questionnaires
  63. Electroencephalography and Dementia: A Literature Review and Future Perspectives
  64. Paucisymptomatic Marchiafava–Bignami disease with relevant diffusion-weighted MRI lesions
  65. Unilateral spatial neglect and alien limb phenomenon may be early features of Creutzfeldt–Jakob disease
  66. Increased cortical excitability after selective REM sleep deprivation in healthy humans: A transcranial magnetic stimulation study
  67. Effects of zonisamide as add-on therapy on sleep-wake cycle in focal epilepsy: A polysomnographic study
  68. Sleep and Epilepsy
  69. Sleep-Wake Cycle and Daytime Sleepiness in the Myotonic Dystrophies
  70. Spasticity as an ictal pattern due to excitotoxic upper motor neuron damage
  71. Pure ictal sensory seizures may represent a clinical manifestation of PLEDs
  72. Sleep disorders in adult-onset myotonic dystrophy type 1: a controlled polysomnographic study
  73. Cognitive profile and brain morphological changes in obstructive sleep apnea
  74. Non-motor functions in parkinsonian patients implanted in the pedunculopontine nucleus: Focus on sleep and cognitive domains
  75. Late-onset MNGIE without peripheral neuropathy due to incomplete loss of thymidine phosphorylase activity
  76. Cerebrospinal fluid levels of the endocannabinoid anandamide are reduced in patients with untreated newly diagnosed temporal lobe epilepsy
  77. Pregabalin as add-on therapy induces REM sleep enhancement in partial epilepsy: a polysomnographic study
  78. ICTAL Aphasia as Manifestation of Partial Status Epilepticus in a Long-Lasting Misdiagnosed Symptomatic Epilepsy: An Emblematic Case
  79. Effective treatment of narcolepsy–cataplexy with duloxetine: A report of three cases
  80. Oxcarbazepine in Nocturnal Frontal-Lobe Epilepsy: A Further Interesting Report
  81. Sleep-wake cycle and effects of cabergoline monotherapy in de novo Parkinson’s disease patients
  82. Corrigendum
  83. Pedunculopontine nucleus stimulation influences REM sleep in Parkinson’s disease
  84. Cognitive and psychiatric effects of topiramate monotherapy in migraine treatment: an open study
  85. Topiramate-induced restless legs syndrome
  86. Carotid Artery Stenting With Filter Protection in High-Risk Patients Showing Severe Electroencephalographic Alterations During Carotid Endarterectomy
  87. Effect of cabergoline added to levodopa treatment on sleep-wake cycle in idiopathic Parkinson’s disease: an open label 24-hour polysomnographic study
  88. Sleep episodes and daytime somnolence as result of individual susceptibility to different dopaminergic drugs in a PD patient: a polysomnographic study
  89. Baroreflex Buffering of Sympathetic Activation During Sleep: Evidence From Autonomic Assessment of Sleep Macroarchitecture and Microarchitecture
  90. Topiramate: effect on EEG interictal abnormalities and background activity in patients affected by focal epilepsy
  91. Bilateral frontal polymicrogyria and epilepsy in a patient with Turner mosaicism: a case report
  92. Sleep-related changes in baroreflex sensitivity and cardiovascular autonomic modulation
  93. Quantitative EEG and dynamic susceptibility contrast MRI in Alzheimer's disease: a correlative study
  94. QUANTITATIVE EEG PATTERNS FOLLOWING UNILATERAL STROKE: A STUDY IN CHRONIC STAGE
  95. Clinical Case Report: CORTICAL DYSPLASIA, TEMPORAL ATROPHY, MENTAL RETARDATION, DYSMORPHIC FACIES, AND PARTIAL EPILEPSY: AN EEG AND DYNAMIC SUSCEPTIBILITY CONTRAST (DSC) MRI STUDY IN A NEW POSSIBLE GENETIC SYNDROME
  96. Dynamic Susceptibility Contrast (DSC) MRI and Interictal Epileptiform Activity in Cryptogenic Partial Epilepsy
  97. Ketotic hyperglycemia and epilepsia partialis continua
  98. Gabapentin-induced modulation of interictal epileptiform activity related to different vigilance levels
  99. Effect of antiepileptic drugs on sleep
  100. Gabapentin as add-on therapy in focal epilepsy: a computerized EEG study
  101. Changes of the Eeg Paroxysmal Pattern During Felbamate Therapy in Lennox-Gastaut Syndrome: A Case Report